Cargando…
Radical Cystectomy Against Intravesical BCG for High-Risk High-Grade Nonmuscle Invasive Bladder Cancer: Results From the Randomized Controlled BRAVO-Feasibility Study
High-grade nonmuscle invasive bladder cancer (HRNMIBC) is a heterogeneous disease. Treatments include intravesical maintenance Bacillus Calmette-Guerin (mBCG) and radical cystectomy (RC). We wanted to understand whether a randomized trial comparing these options was possible. MATERIALS AND METHODS:...
Autores principales: | Catto, James W. F., Gordon, Kathryn, Collinson, Michelle, Poad, Heather, Twiddy, Maureen, Johnson, Mark, Jain, Sunjay, Chahal, Rohit, Simms, Matt, Dooldeniya, Mohantha, Bell, Richard, Koenig, Phillip, Conroy, Samantha, Goodwin, Louise, Noon, Aidan P., Croft, Julie, Brown, Julia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078404/ https://www.ncbi.nlm.nih.gov/pubmed/33332191 http://dx.doi.org/10.1200/JCO.20.01665 |
Ejemplares similares
-
Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk non-muscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study
por: Oughton, Jamie B, et al.
Publicado: (2017) -
Radical cystectomy in the elderly – Is this a safe treatment option?
por: Young, Matthew J., et al.
Publicado: (2017) -
A retrospective analysis of patients treated with intravesical BCG for high-risk nonmuscle invasive bladder cancer
por: Joshua, Julie Mariam, et al.
Publicado: (2019) -
Radical Cystectomy after BCG Immunotherapy for High-Risk Nonmuscle-Invasive Bladder Cancer in Patients with Previous Prostate Radiotherapy
por: Rao, Manoj V., et al.
Publicado: (2013) -
Definitive BCG immunotherapy versus radical cystectomy in intermediate or high-risk nonmuscle invasive bladder cancer patients: A retrospective study
por: Jian, Xiaoming, et al.
Publicado: (2019)